1. Home
  2. BON vs NKGN Comparison

BON vs NKGN Comparison

Compare BON & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BON
  • NKGN
  • Stock Information
  • Founded
  • BON 2006
  • NKGN 2017
  • Country
  • BON China
  • NKGN United States
  • Employees
  • BON N/A
  • NKGN N/A
  • Industry
  • BON Medicinal Chemicals and Botanical Products
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BON Health Care
  • NKGN Health Care
  • Exchange
  • BON Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • BON 9.9M
  • NKGN 9.5M
  • IPO Year
  • BON 2021
  • NKGN N/A
  • Fundamental
  • Price
  • BON $1.58
  • NKGN $0.34
  • Analyst Decision
  • BON
  • NKGN
  • Analyst Count
  • BON 0
  • NKGN 0
  • Target Price
  • BON N/A
  • NKGN N/A
  • AVG Volume (30 Days)
  • BON 13.4K
  • NKGN 900.0K
  • Earning Date
  • BON 11-29-2024
  • NKGN 11-26-2024
  • Dividend Yield
  • BON N/A
  • NKGN N/A
  • EPS Growth
  • BON N/A
  • NKGN N/A
  • EPS
  • BON 2.19
  • NKGN N/A
  • Revenue
  • BON $25,555,939.00
  • NKGN N/A
  • Revenue This Year
  • BON $47.04
  • NKGN N/A
  • Revenue Next Year
  • BON $77.63
  • NKGN N/A
  • P/E Ratio
  • BON $0.67
  • NKGN N/A
  • Revenue Growth
  • BON N/A
  • NKGN N/A
  • 52 Week Low
  • BON $1.23
  • NKGN $0.20
  • 52 Week High
  • BON $6.99
  • NKGN $4.06
  • Technical
  • Relative Strength Index (RSI)
  • BON 57.03
  • NKGN 52.26
  • Support Level
  • BON $1.35
  • NKGN $0.26
  • Resistance Level
  • BON $1.56
  • NKGN $0.33
  • Average True Range (ATR)
  • BON 0.11
  • NKGN 0.04
  • MACD
  • BON 0.02
  • NKGN 0.01
  • Stochastic Oscillator
  • BON 82.41
  • NKGN 50.97

About BON Bon Natural Life Limited

Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The company has its geographic presence in PRC and in Overseas.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: